Advanced Cardiovascular and Metabolic Therapeutics for Global Healthcare

We present a comprehensive and strategically designed Cardiovascular & Metabolic Product Portfolio developed by Taj Pharma India Ltd., addressing the full spectrum of hypertension, heart failure, dyslipidemia, ischemic heart disease, arrhythmias, thromboembolic disorders, and metabolic syndrome. Our formulations are developed to meet international regulatory expectations, therapeutic precision, and global market demand, making Taj Pharma a reliable partner for regulated and semi-regulated markets worldwide.

This portfolio integrates single-molecule therapies, fixed-dose combinations (FDCs), and modified-release formulations, ensuring enhanced patient compliance, optimized pharmacokinetics, and evidence-based cardiovascular risk reduction.


Why Taj Pharma’s Cardiovascular & Metabolic Range Stands Out

  • WHO-GMP compliant manufacturing
  • BCS-based formulation strategy
  • Export-ready dossier support
  • Broad strength variations
  • Cost-effective yet premium-quality medicines
  • Suitable for chronic, long-term therapy

Our approach focuses on clinical relevance, therapeutic continuity, and market adaptability, enabling healthcare providers and distributors to cover diverse patient populations with confidence.

Taj Pharma – Cardiovascular & Metabolic Product

Product NameBrand Name (Taj-style)Therapeutic CategoryDosage FormAvailable StrengthsBCS Class (Estimate)
Trimetazidine MRTrimeTaj MRAnti-anginalTablet (MR)60 mgI
Torsemide + SpironolactoneTorSpiroTajDiuretic CombinationTablet10 mg + 50 mgIV
TorsemideTorseTajLoop DiureticTablet10 mg, 20 mgIV
Telmisartan + CilnidipineTelCilniTajAntihypertensiveTablet40 mg + 10 mg, 40 mg + 20 mgII
Telmisartan + HydrochlorothiazideTelHCTajAntihypertensiveTablet40/12.5 mg, 80/12.5 mgII
Telmisartan + Amlodipine + HCTZTelAmloHCTajAntihypertensiveFC Tablet20/2.5/6.25 mgII
Telmisartan + Amlodipine + ChlorthalidoneTelAmloChlorTajAntihypertensiveTablet40/5/12.5 mgII
Telmisartan + ChlorthalidoneTelChlorTajAntihypertensiveTablet80 mg + 12.5 mgII
TelmisartanTelmiTajAntihypertensiveTablet40 mg, 80 mgII
Sacubitril + ValsartanSacuValTajHeart FailureTablet24/26 mg, 49/51 mgIII
Losartan + HydrochlorothiazideLosarHCTajAntihypertensiveTablet50/12.5 mgII
RosuvastatinRosuTajLipid-LoweringTablet5 mg, 10 mg, 40 mgII
RivaroxabanRivaTajAnticoagulantTablet10 mgII
AmlodipineAmloTajAntihypertensiveFC Tablet10 mgI
Amlodipine + AtenololAmloAtenTajAntihypertensiveTablet5/50 mgI
ApixabanApiTajAnticoagulantTablet2.5 mgIII
AtenololAtenoTajBeta-BlockerTablet50 mgIII
Atorvastatin + EzetimibeAtorEzeTajLipid-LoweringTablet10/10 mgII
Atorvastatin + FenofibrateAtorFenoTajLipid-LoweringTablet10/160 mgII
AtorvastatinAtorTajLipid-LoweringTablet10 mgII
AzilsartanAzilTajAntihypertensiveTablet40 mgII
Azilsartan + ChlorthalidoneAzilChlorTajAntihypertensiveTablet40/6.25 mgII
Chlorthalidone + OlmesartanOlmeChlorTajAntihypertensiveTablet20/12.5 mgII
ChlorthalidoneChlorTajDiureticTablet12.5 mgIV
CilnidipineCilniTajAntihypertensiveTablet10 mg, 20 mgII
Clonidine HClCloniTajAntihypertensiveTablet0.1 mgI
EnalaprilEnalaTajACE InhibitorTablet5 mg, 10 mgIII
EplerenoneEpleTajAldosterone AntagonistTablet25 mgII
EplrestatEplresTajAldose Reductase InhibitorTablet50 mgII
HydrochlorothiazideHCTajDiureticTablet12.5 mgIV
BisoprololBisoTajBeta-BlockerTablet5 mgI
Bisoprolol + AmlodipineBisoAmloTajAntihypertensiveTablet5/5 mgI
Bisoprolol + HCTZBisoHCTajAntihypertensiveTablet5/6.25 mgI
IvabradineIvabraTajAnti-anginalTablet5 mgII
LabetalolLabeTajAntihypertensiveTablet100 mgI
LosartanLosarTajAntihypertensiveTablet50 mgII
MetolazoneMetozaTajThiazide-like DiureticTablet2.5 mg, 5 mgIV
Metoprolol Succinate ERMetoSuccTajBeta-BlockerER Tablet12.5 mg, 25 mg, 50 mgI
Metoprolol + TelmisartanMetoTelmiTajAntihypertensiveTablet25/20 mg, 50/40 mgI
Metoprolol TartrateMetoTartTajBeta-BlockerTablet25 mgI
MidodrineMidoTajVasopressorTablet2.5 mgIII
MoxonidineMoxoTajAntihypertensiveTablet0.3 mgII
Olmesartan + Amlodipine + ChlorthalidoneOlmeAmloChlorTajAntihypertensiveTablet20/5/12.5 mgII
Olmesartan + AmlodipineOlmeAmloTajAntihypertensiveTablet20/5 mgII
Olmesartan + HCTZOlmeHCTajAntihypertensiveTablet20/12.5 mgII
OlmesartanOlmeTajAntihypertensiveTablet20 mgII
PerindoprilPerindoTajACE InhibitorTablet4 mgII
Prazosin SRPrazoTaj SRAlpha-BlockerSR Tablet2.5 mgI
Propranolol SRPropranoTaj SRBeta-BlockerSR Tablet40 mgI
PropranololPropranoTajBeta-BlockerTablet10 mg, 20 mg, 40 mgI
RamiprilRamiTajACE InhibitorTablet1.25 mg, 2.5 mg, 5 mgIII
Ramipril + HCTZRamiHCTajAntihypertensiveTablet5/12.5 mgIII
RanitidineRaniTajH2 BlockerTablet150 mgIII
Ranolazine ERRanolaTaj ERAnti-anginalER Tablet1000 mgII
NebivololNebiTajBeta-BlockerTablet5 mgII
BenidipineBeniTajCalcium Channel BlockerTablet4 mgII

Anti-Anginal & Ischemic Heart Disease Therapies

Trimetazidine MR – TrimeTaj MR

A cornerstone metabolic anti-anginal therapy, TrimeTaj MR (60 mg) enhances myocardial glucose utilization, improving exercise tolerance without affecting heart rate or blood pressure. Its modified-release profile ensures stable plasma levels and better patient adherence.

Ivabradine – IvabraTaj

Designed to selectively reduce heart rate via If-channel inhibition, IvabraTaj (5 mg) is ideal for chronic stable angina and heart failure patients intolerant to beta-blockers.

Ranolazine ER – RanolaTaj ER

RanolaTaj ER (1000 mg) delivers sustained anti-anginal efficacy by reducing late sodium current, improving myocardial relaxation and oxygen efficiency.


Comprehensive Antihypertensive Portfolio

Hypertension management often requires multi-mechanism therapy, and our portfolio reflects this clinical reality.

Angiotensin Receptor Blockers (ARBs)

  • TelmiTaj (Telmisartan 40 mg, 80 mg)
  • LosarTaj (Losartan 50 mg)
  • OlmeTaj (Olmesartan 20 mg)
  • AzilTaj (Azilsartan 40 mg)

These agents provide renoprotective and cardioprotective benefits, especially suitable for diabetic and metabolic syndrome patients.

ARB-Based Fixed Dose Combinations

  • TelCilniTaj (Telmisartan + Cilnidipine)
  • TelHCTaj (Telmisartan + Hydrochlorothiazide)
  • TelAmloHCTaj
  • TelAmloChlorTaj
  • SacuValTaj (Sacubitril + Valsartan)

These combinations enhance blood pressure control, reduce pill burden, and improve long-term compliance.


Beta-Blockers and Heart Rate Modulators

Cardioselective Beta-Blockers

  • BisoTaj (Bisoprolol 5 mg)
  • NebiTaj (Nebivolol 5 mg)
  • MetoSuccTaj (Metoprolol Succinate ER)

These agents are essential in ischemic heart disease, chronic heart failure, and post-MI management.

Non-Selective & Combination Beta-Blockers

  • PropranoTaj / PropranoTaj SR
  • AmloAtenTaj (Amlodipine + Atenolol)

Designed for hypertension with tachycardia, anxiety-related cardiovascular symptoms, and portal hypertension.


Diuretics & Volume Management Solutions

Effective fluid management is critical in heart failure and resistant hypertension.

  • TorseTaj (Torsemide 10 mg, 20 mg)
  • TorSpiroTaj (Torsemide + Spironolactone)
  • ChlorTaj (Chlorthalidone 12.5 mg)
  • HCTaj (Hydrochlorothiazide 12.5 mg)
  • MetozaTaj (Metolazone 2.5 mg, 5 mg)

These agents support decongestion, preload reduction, and blood pressure optimization.


Lipid-Lowering & Anti-Atherosclerotic Therapies

Statins and Combinations

  • RosuTaj (5 mg, 10 mg, 40 mg)
  • AtorTaj (10 mg)
  • AtorEzeTaj (Atorvastatin + Ezetimibe)
  • AtorFenoTaj (Atorvastatin + Fenofibrate)

These formulations target LDL reduction, triglyceride control, and plaque stabilization, essential in primary and secondary prevention.


Anticoagulants & Antithrombotic Agents

  • RivaTaj (Rivaroxaban 10 mg)
  • ApiTaj (Apixaban 2.5 mg)

Our NOAC portfolio supports stroke prevention in atrial fibrillation and venous thromboembolism management with predictable pharmacokinetics and minimal monitoring.


Heart Failure & Specialized Cardiovascular Agents

Aldosterone Antagonists

  • EpleTaj (Eplerenone 25 mg)

Vasopressors & Central Agents

  • MidoTaj (Midodrine 2.5 mg)
  • MoxoTaj (Moxonidine 0.3 mg)

Alpha Blockers

  • PrazoTaj SR (Prazosin SR 2.5 mg)

These therapiesML therapies cater to autonomic dysfunction, resistant hypertension, and heart failure optimization.


BCS-Based Formulation Excellence

Each product is developed considering its Biopharmaceutics Classification System (BCS) class, ensuring:

  • Optimized dissolution
  • Bioequivalence readiness
  • Regulatory compliance
  • Stable scale-up and commercialization

Global Manufacturing & Export Readiness

All products are manufactured at Taj Pharma India Ltd., Sarigam, Gujarat, under stringent quality systems. We provide:

  • CTD & ACTD dossiers
  • Stability data
  • Custom labeling & branding
  • Regulatory support for ROW markets

Partner with Taj Pharma India Ltd.

We invite importers, distributors, hospital buyers, and government suppliers to collaborate with us for sustainable growth in cardiovascular and metabolic therapy markets.

TAJ PHARMA INDIA LTD.
Plot No.1019, Vill. – Sarigam, G.I.D.C.,
Road No.10, Dist. – Valsad,
Gujarat, India – 396155
📍 Plant Location: https://g.co/kgs/WrD9gQQ
📞 For Assistance: +91 90995 11459 / +91 99040 00567